RxDoctor Payments Data

Sylvia Hanson, MD

Psychiatry · Battle Creek, MINPI 1962509661

Payments from drug & device makers

$1,631in general payments, 2019–2025

Across 113 payments — averaging $14.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$291
  • Alkermes, Inc.$220
  • Teva Pharmaceuticals USA, Inc.$204
  • Validus Pharmaceuticals LLC$194
  • AbbVie$164
  • Neurocrine Biosciences, Inc.$163
  • plus $395 from 7 others

What the payments were for

  • Food & beverage$1,625100%
  • Gifts$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,631 in reported general payments places this provider in the 80th percentile of 1,166 psychiatry providers in Michigan.

See all psychiatry providers in Michigan

Medicare billing

Part B allowed, 2024
$29,090
Medicare patients
55
Services billed
346

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole49$139,159
Invega SustennaPaliperidone Palmitate42$114,899
AristadaAripiprazole Lauroxil39$111,943
IngrezzaValbenazine Tosylate12$91,754
VraylarCariprazine Hcl57$78,021
Aripiprazole139$12,204
TrintellixVortioxetine Hydrobromide25$11,417
Fluphenazine Hcl111$9,911
Fluphenazine Decanoate56$6,046
Lurasidone Hcl12$3,356
Olanzapine173$2,818
Carbamazepine ErCarbamazepine31$2,679
Venlafaxine Hcl ErVenlafaxine Hcl51$2,541
Quetiapine Fumarate300$2,501
Clozapine47$2,001

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$102$139,15949 claims
Johnson & JohnsonInvega Sustenna$291$114,89942 claims
Alkermes, Inc.Aristada$220$111,94339 claims
Neurocrine Biosciences, Inc.Ingrezza$163$91,75412 claims
AbbVieVraylar$164$78,02157 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$17$11,41725 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,166 psychiatry providers in Michigan.

Other psychiatry in Battle Creek

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →